Debates & Insight Sponsored Available on demand: What will changes to England's pharmacy... New measures proposed by the Government will impact community pharmacies across the UK.
Articles Healthcare systems aren’t making the most of biosimilars: ph... Biosimilars could save European and US healthcare systems billions - but more needs to be done to maximise their benefits, writes Richard Staines.
Articles Manchester's devolution revolution: will pharma get a seat a... Manchester will lead the way towards integrated care
R&D Reuters Pharma Europe 2024 – Peter Stenico Pioneering access to biosimilars is crucial for strengthening health equity by providing affordable, life-changing therapies to patients worldwide.
Digital Fixing clinical trial data management It’s 2024, and in most clinical trials, data is still being moved from the EHR to the EDC manually – with employees reading data from one screen and typing it onto another.